[1]
“Evaluation of the effectiveness of the ‘TRIO’ pharmacotherapy regimen in patients with chronic arterial insufficiency IIb-III”, prmd, vol. 3, no. 1, pp. 4–9, Jun. 2020, doi: 10.31636/prmd.v3i1.1.